Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

A Phase 1, Open-label Study of the absorption, metabolism, and excretion of a single oral dose of \[14C\]TVB-2640 healthy male subjects.

Key facts

Study ID

NCT05657834

Run by

Sagimet Biosciences Inc.

People needed

8

Starts

2022-11-21

Expected to finish

2022-12-21

Last updated by the study team

2022-12-28

Who can join

Age: 19 and older, up to 55. Sex: male. Healthy volunteers: accepted.

Where it is running

• Celerion Inc. — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.